Clinical Trial Update: A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating gemcabene for efficacy, safety, and tolerability in adults with severe hypertriglyceridemia (completed; results posted).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia
• Mixed Dyslipidaemia

Drugs mentioned

• gemcabene (gemcabene)

Snippet

Sponsor: NeuroBo Pharmaceuticals Inc. | Conditions: Severe Hypertriglyceridemia, Mixed Dyslipidaemia | Phase 2 | Status: COMPLETED | Results posted: 2020-06-25